Literature DB >> 18955814

Isolation and structure determination of a proteasome inhibitory metabolite from a culture of Scytonema hofmanni.

Sang Hee Shim1, George Chlipala, Jimmy Orjala.   

Abstract

Cyanobacteria, blue-green algae, are a rich source of bioactive secondary metabolites with many potential applications. The ubiquitin-proteasome proteolytic system plays an important role in selective protein degradation and regulates cellular events including apoptosis. Cancer cells are more sensitive to the proapoptotic effects of proteasome inhibition than normal cells. Thus, proteasome inhibitors can be potential anticancer agents. Cyanobacteria have been shown to be a rich source of highly effective inhibitors of proteases. A proteasome inhibitor was screened from an extract of the culture of Scytonema hofmanni on the basis of its inhibitory activity, which led to the isolation of nostodione A with an IC(50) value of 50 microM. Its structure was determined by spectroscopic methods such as 1H-NMR and ESI-MS spectral analyses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18955814      PMCID: PMC2963942     

Source DB:  PubMed          Journal:  J Microbiol Biotechnol        ISSN: 1017-7825            Impact factor:   2.351


  18 in total

Review 1.  Nitrogen-containing metabolites from marine cyanobacteria.

Authors:  W H Gerwick; L T Tan; N Sitachitta
Journal:  Alkaloids Chem Biol       Date:  2001

Review 2.  The ubiquitin-proteasome pathway and proteasome inhibitors.

Authors:  J Myung; K B Kim; C M Crews
Journal:  Med Res Rev       Date:  2001-07       Impact factor: 12.944

3.  Scyptolin A and B, cyclic depsipeptides from axenic cultures of Scytonema hofmanni PCC 7110.

Authors:  U Matern; L Oberer; R A Falchetto; M Erhard; W A König; M Herdman; J Weckesser
Journal:  Phytochemistry       Date:  2001-12       Impact factor: 4.072

4.  New apratoxins of marine cyanobacterial origin from Guam and Palau.

Authors:  Hendrik Luesch; Wesley Y Yoshida; Richard E Moore; Valerie J Paul
Journal:  Bioorg Med Chem       Date:  2002-06       Impact factor: 3.641

Review 5.  Serine proteases inhibiting cyanopeptides.

Authors:  G Radau
Journal:  Pharmazie       Date:  2000-08       Impact factor: 1.267

6.  Bortezomib.

Authors:  Andrew Paramore; Simon Frantz
Journal:  Nat Rev Drug Discov       Date:  2003-08       Impact factor: 84.694

7.  Total structure determination of apratoxin A, a potent novel cytotoxin from the marine cyanobacterium Lyngbya majuscula.

Authors:  H Luesch; W Y Yoshida; R E Moore; V J Paul; T H Corbett
Journal:  J Am Chem Soc       Date:  2001-06-13       Impact factor: 15.419

8.  Microcystins (cyanobacterial toxins) in drinking water enhance the growth of aberrant crypt foci in the mouse colon.

Authors:  A R Humpage; S J Hardy; E J Moore; S M Froscio; I R Falconer
Journal:  J Toxicol Environ Health A       Date:  2000-10-13

9.  Hofmannolin, a cyanopeptolin from Scytonema hofmanni PCC 7110.

Authors:  Ute Matern; Lukas Oberer; Marcel Erhard; Michael Herdman; Jürgen Weckesser
Journal:  Phytochemistry       Date:  2003-11       Impact factor: 4.072

Review 10.  Bortezomib (PS-341): a novel, first-in-class proteasome inhibitor for the treatment of multiple myeloma and other cancers.

Authors:  Paul G Richardson; Teru Hideshima; Kenneth C Anderson
Journal:  Cancer Control       Date:  2003 Sep-Oct       Impact factor: 3.302

View more
  3 in total

1.  Comparison of three cell-based drug screening platforms for HSV-1 infection.

Authors:  Leonardo D'Aiuto; Kelly Williamson; Peter Dimitrion; James McNulty; Carla E Brown; Chanti Babu Dokuburra; Alexander J Nielsen; Wen Jing Lin; Paolo Piazza; Mark E Schurdak; Joel Wood; Robert H Yolken; Paul R Kinchington; David C Bloom; Vishwajit L Nimgaonkar
Journal:  Antiviral Res       Date:  2017-03-23       Impact factor: 5.970

2.  A Report on Finding a New Peptide Aldehyde from Cyanobacterium Nostoc sp. Bahar M by LC-MS and Marfey's Analysis.

Authors:  Bahareh Nowruzi; Matti Wahlsten; Jouni Jokela
Journal:  Iran J Biotechnol       Date:  2019-04-20       Impact factor: 1.671

3.  Nostocyclopeptides as New Inhibitors of 20S Proteasome.

Authors:  Anna Fidor; Katarzyna Cekała; Ewa Wieczerzak; Marta Cegłowska; Franciszek Kasprzykowski; Christine Edwards; Hanna Mazur-Marzec
Journal:  Biomolecules       Date:  2021-10-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.